Thermo Fisher Scientific Inc. (TMO)

Check out top investors' recommendation for TMO
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. The company’s Analytical Technologies segment offers instruments, reagents, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. Its Specialty Diagnostics segment provides diagnostic test kits, culture media, instruments, and associated products that are used in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. This segment offers blood-test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, calibrators, and controls and calibration verification fluids; dehydrated and prepared culture media, and collection and transport systems; and products for cancer diagnosis and medical research. The company’s Laboratory Products and Services segment offers laboratory equipment, including sample preparation and preservation equipment, cold storage equipment, centrifugation products, biological safety cabinets, temperature control products, and other laboratory equipment; laboratory consumables; research and safety market solutions; and biopharma services. Thermo Fisher Scientific Inc. serves pharmaceutical and biotechnology companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies, as well as environmental and industrial process control settings. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Sung Ji Nam Cantor Fitzgerald Buy   May 24, '18     260.00  May 24, '19  N/A 
Steve Beuchaw Morgan Stanley Buy   Apr 11, '18     216.00  Apr 11, '19  N/A 
Steve Beuchaw Morgan Stanley Buy   Feb 01, '18     227.00  Feb 01, '19  N/A 
Doug Schenkel Cowen And Company Buy   Jan 31, '18     220.00  Jan 31, '19  N/A 
Sung Ji Nam Cantor Fitzgerald Buy   Jan 05, '18     230.00  Jan 05, '19  N/A 
Ross Muken ISI Group Buy   Jan 03, '18     220.00  Jan 03, '19  N/A 
Steve Beuchaw Morgan Stanley Buy   Oct 30, '17     220.00  Oct 30, '18  N/A 
Dan Leonard Leerink Swann Llc Buy   Oct 26, '17     226.00  Oct 26, '18  N/A 
Doug Schenkel Cowen And Company Buy   Oct 11, '17     220.00  Oct 11, '18  N/A 
Doug Schenkel Cowen And Company Buy   Sep 08, '17     220.00  Sep 08, '18  N/A 
Steve Beuchaw Morgan Stanley Buy   Sep 06, '17     220.00  Sep 06, '18  N/A 
David Toung Argus Research Company Buy   Aug 22, '17     200.00  Aug 22, '18  N/A 
Steve Willoughby Cleveland Research Company Buy   Jul 20, '17     206.00  Jul 20, '18  N/A 
Bryan Brokmeier Maxim Group Buy   May 18, '17     194.00  May 18, '18  N/A 
Daniel Brennan Morgan Stanley Buy   Apr 28, '17     192.00  Apr 28, '18  N/A 
Dan Leonard Leerink Swann Llc Buy   Apr 27, '17     187.00  Apr 27, '18  N/A 
Dan Leonard Leerink Swann Llc Buy   Jan 18, '17     163.00  Jan 18, '18  N/A 
Derik De Bruin BofA Merrill Lynch Buy   Oct 07, '16     180.00  Oct 07, '17  N/A 
Tycho Peterson JPMorgan Buy   Sep 22, '16       Sep 22, '17  N/A 
Amit Bhalla Citi Buy   Jul 29, '16     182.00  Jul 29, '17  N/A 
< previous1234